{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:56:34Z","timestamp":1781664994849,"version":"3.54.5"},"reference-count":33,"publisher":"Norwegian Medical Association","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"published-print":{"date-parts":[[2010,9,9]]},"DOI":"10.4045\/tidsskr.09.0792","type":"journal-article","created":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T08:00:11Z","timestamp":1284364811000},"page":"1717-20","source":"Crossref","is-referenced-by-count":2,"title":["Intraven\u00f8s IgG-behandling av nevromuskul\u00e6re sykdommer"],"prefix":"10.4045","volume":"130","author":[{"given":"Christian","family":"Vedeler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svein Ivar","family":"Mellgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roald","family":"Omdal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torberg","family":"Torbergsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Aasly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Provan D, Chapel HM, Sewell WAC et al. Prescribing intravenous immunoglobulin: summary of Department of Health guidelines. BMJ 2008; 337: 990\u2009\u2013\u20092. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18936060&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136\/bmj.a1831","DOI":"10.1136\/bmj.a1831"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Elovaara I, Apostolski S, van Doorn P et al. EFNS guidelines for the use of intravenous immunglobulin treatment of neurological diseases. Eur J Neurol 2008; 15: 893\u2009\u2013\u2009908. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18796075&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1468-1331.2008.02246.x","DOI":"10.1111\/j.1468-1331.2008.02246.x"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Nimmerjahn F, Ravetch JV. Anti-inflammatory actions of intravenous immunoglobulin. Annu Rev Immunol 2008; 26: 513\u2009\u2013\u200933. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18370923&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1146\/annurev.immunol.26.021607.090232","DOI":"10.1146\/annurev.immunol.26.021607.090232"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Raphael JC, Chevret S, Hughes RAC et al. Plasma exchange for Guillain-Barre syndrome. Cochrane Database of Systematic Reviews 2002; nr. 2, CD001798. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12076424&dopt=Abstract","DOI":"10.1002\/14651858.CD001798"},{"key":"ref=5","unstructured":"Hughes RA, Raphael JC, Swan AV et al. Intravenous immunoglobulin for Guillain-Barre syndrome. Cochrane Database of Systematic Reviews 2006; nr. 1: CD002063. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16437439&dopt=Abstract"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Farcas P, Avnum L, Frisher S et al. Efficacy of repeated intravenous immunoglobulin in severe unresponsive Guillain-Barre syndrome. Lancet 1997; 350: 13. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9413468&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S0140-6736(97)24050-X","DOI":"10.1016\/S0140-6736(97)24050-X"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Eftimov F, Winer JB, Vermeulen M et al. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database of Systematic Reviews 2009, nr. 1: CD001797. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19160200&dopt=Abstract","DOI":"10.1002\/14651858.CD001797.pub2"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Hughes RA, Donofrio P, Bril V et al. Intravenous immune globulin (10\u00a0% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Lancet Neurol 2008; 7: 136\u2009\u2013\u200944. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18178525&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S1474-4422(07)70329-0","DOI":"10.1016\/S1474-4422(07)70329-0"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"van Schaik IN, van den Berg LH, de Haan R et al. Intravenous immunoglobulin for multifocal motor neuropathy. Cochrane Database of Systematic Reviews 2005; nr. 2: CD004429. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15846714&dopt=Abstract","DOI":"10.1002\/14651858.CD004429.pub2"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Comi G, Roveri L, Swan A et al. A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy. J Neurol 2007; 247: 1370\u2009\u2013\u20097. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12382151&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007\/s00415-002-0808-z","DOI":"10.1007\/s00415-002-0808-z"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Uchuya M, Graus F, Vega F et al. Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineural autoantibodies. J Neurol Neurosurg Psychiatry 1996; 60: 388\u2009\u2013\u200992. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8774401&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136\/jnnp.60.4.388","DOI":"10.1136\/jnnp.60.4.388"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Keime-Guibert F, Graus F, Fleury A et al. Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry 2000; 68: 479\u2009\u2013\u200982. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10727484&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136\/jnnp.68.4.479","DOI":"10.1136\/jnnp.68.4.479"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Levy Y, Uziel Y, Zandman GG et al. Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis. Ann Rheum Dis 2003; 62: 1221\u2009\u2013\u20093. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14644864&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136\/ard.2002.003996","DOI":"10.1136\/ard.2002.003996"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Takahashi Y, Takata T, Hoshino M et al. Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sj\u00f6gren\u2019s syndrome. Neurology 2003; 60: 503\u2009\u2013\u20095. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12578938&dopt=Abstract","DOI":"10.1212\/01.WNL.0000046680.47883.7D"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Bain PG, Motomura M, Newsom-Davis J et al. Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in\u00a0the Lambert-Eaton myasthenic syndrome. Neurology 1996; 47: 678\u2009\u2013\u200983. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8797464&dopt=Abstract","DOI":"10.1212\/WNL.47.3.678"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Ishii A, Hayashi A, Ohkoshi N et al. Clinical evaluation of plasma exchange and high dose intravenous immunoglobulin in a patient with Isaacs\u2019 syndrome. J Neurol Neurosurg Psychiatry 1994; 57: 840\u2009\u2013\u20092. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8021673&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136\/jnnp.57.7.840","DOI":"10.1136\/jnnp.57.7.840"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"Alessi G, De Reuck J, De Bleecker J et al. Successful immunoglobulin treatment in a patients with neuromyotonia. Clin Neurol Neurosurg 2000; 102: 173\u2009\u2013\u20095. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10996718&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S0303-8467(00)00093-7","DOI":"10.1016\/S0303-8467(00)00093-7"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"Gajdos P, Chevret S, Toyka KV. Intravenous immunoglobulin for myasthenia gravis. Cochrane Database of Systematic Reviews 2008; nr. 1: CD002277. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18254004&dopt=Abstract","DOI":"10.1002\/14651858.CD002277.pub3"},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"Jensen P, Bril V. A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis. J Clin Neuromuscul Dis 2008; 9: 352\u2009\u2013\u20095. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18344718&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097\/CND.0b013e3181660807","DOI":"10.1097\/CND.0b013e3181660807"},{"key":"ref=20","doi-asserted-by":"crossref","unstructured":"Cherin P, Pelletier S, Teixeira A et al. Results and long term follow up of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients. Arthritis Rheum 2002; 46: 467\u2009\u2013\u200974. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11840450&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002\/art.10053","DOI":"10.1002\/art.10053"},{"key":"ref=21","unstructured":"Cherin P, Piette JC, Wechsler B et al. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients. J Rheumatol 1994; 21: 1092\u2009\u2013\u20097. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7932419&dopt=Abstract"},{"key":"ref=22","doi-asserted-by":"crossref","unstructured":"Danieli MG, Malcangi G, Palmieri C et al. Cyclosporin A and intravenous immunoglobulin treatment in polymyositis\/dermatomyositis. Ann Rheum Dis 2002; 61: 37\u2009\u2013\u200941. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11779756&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136\/ard.61.1.37","DOI":"10.1136\/ard.61.1.37"},{"key":"ref=23","doi-asserted-by":"crossref","unstructured":"Dalakas MC, Illa I, Dambrosia JM et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N\u00a0Engl J Med 1993; 329: 1993\u2009\u2013\u20092000. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8247075&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1056\/NEJM199312303292704","DOI":"10.1056\/NEJM199312303292704"},{"key":"ref=24","unstructured":"Al-Mayouf SM, Laxer RM, Schneider R et al. Intravenous immunoglobulin therapy for juvenile dermatomyositis \u2013 efficacy and safety. J Rheumatol 2000; 27: 2498\u2009\u2013\u2009503. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11036850&dopt=Abstract"},{"key":"ref=25","doi-asserted-by":"crossref","unstructured":"Sansome A, Dubowitz V. Intravenous immunoglobulin in juvenile dermatomyositis \u2013 four year review of nine cases. Arch Dis Childhood 1995; 72:\u00a025\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7717731&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136\/adc.72.1.25","DOI":"10.1136\/adc.72.1.25"},{"key":"ref=26","unstructured":"Tsai MJ, Lai CC, Lin SC et al. Intravenous immunoglobulin therapy in juvenile dermatomyositis. Zhonghua Min Guo Xiao Erke Yi Xue Hui Za Zhi 1997; 38: 111\u2009\u2013\u20095. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9151463&dopt=Abstract"},{"key":"ref=27","doi-asserted-by":"crossref","unstructured":"Dalakas MC, Sonies B, Dambrosia J et al. Treatment of inclusion-body myositis with IVIG: a double-blind, placebo controlled study. Neurology 1997; 48: 712\u2009\u2013\u20096. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9065553&dopt=Abstract","DOI":"10.1212\/WNL.48.3.712"},{"key":"ref=28","doi-asserted-by":"crossref","unstructured":"Walter MC, Lochmuller H, Toepfer M et al. High-dose immunoglobulin therapy in sporadic inclusion body myositis: a double-blind, placebo-controlled study. J Neurology 2000; 247: 22\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10701893&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007\/s004150050005","DOI":"10.1007\/s004150050005"},{"key":"ref=29","doi-asserted-by":"crossref","unstructured":"Dalakas MC, Koffman B, Fujii M et al. A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM. Neurology 2001; 56: 323\u2009\u2013\u20097. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11171896&dopt=Abstract","DOI":"10.1212\/WNL.56.3.323"},{"key":"ref=30","doi-asserted-by":"crossref","unstructured":"Gonzalez H, Sunnerhagen KS, Sjoberg I et al. Intravenous immunoglobulin for post-polio syndrome: a randomised controlled trial. Lancet Neurol 2006; 5: 493\u2009\u2013\u2009500. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16713921&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S1474-4422(06)70447-1","DOI":"10.1016\/S1474-4422(06)70447-1"},{"key":"ref=31","doi-asserted-by":"crossref","unstructured":"Farbu E, Rekand T, Vik-Mo E et al. Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study. Eur J Neurol 2007; 14: 60\u2009\u2013\u20095. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17222115&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1468-1331.2006.01552.x","DOI":"10.1111\/j.1468-1331.2006.01552.x"},{"key":"ref=32","doi-asserted-by":"crossref","unstructured":"Dalakas MC, Fujii M, Li M et al. High-dose intravenous immune globulin for stiff-person syndrome. N Engl J Med 2001; 345: 1870\u2009\u2013\u20096. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11756577&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1056\/NEJMoa01167","DOI":"10.1056\/NEJMoa01167"},{"key":"ref=33","doi-asserted-by":"crossref","unstructured":"Raphael J-C, Chevret S, Harboun M et al. Intravenous immune globulins in patients with Guillain-Barre syndrome and contradictions to plasma exchange: 3 days versus 6 days. J Neurol Neurosurg Psychiatry2001; 71: 235\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11459901&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136\/jnnp.71.2.235","DOI":"10.1136\/jnnp.71.2.235"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:45:18Z","timestamp":1781664318000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2010\/09\/oversiktsartikkel\/intravenos-igg-behandling-av-nevromuskulaere-sykdommer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,9]]},"references-count":33,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2010,9,9]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.09.0792","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,9]]}}}